Neuromuscular disease: Genome editing shows promise in an in vivo model of Duchenne muscular dystrophy

Nat Rev Neurol. 2016 Feb;12(2):63. doi: 10.1038/nrneurol.2016.4. Epub 2016 Jan 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • CRISPR-Cas Systems / genetics*
  • Dystrophin / genetics*
  • Genome*
  • Humans
  • Male
  • Muscular Dystrophy, Duchenne / genetics*
  • Mutation*

Substances

  • Dystrophin